Oscar Health Inc. (OSCR) Tops Q4 EPS by 9c

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.05), $0.09 better than the analyst estimate of ($1.14). Revenue for the quarter came in at $995 million versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• U.S. economy adds 199,000 jobs in November
• Smith & Wesson Brands (SWBI) Misses Q2 EPS by 4c
• Virco Mfg. Corp. (VIRC) Tops Q3 EPS by 23c